Basically, pyroglutamate is, like piracetam, a mild 'normalizing' agent subtly effecting cognitive processes. It reduces the effects of depressants like barbiturates and alcohol.

"In the case of pentobarbital the antagonistic effect of the compound on the general anaesthesia is very intense and is equally present even when medazepam and flurazepam are associated. Equally obvious is the antagonism with barbiturate in the case of spontaneous motility but much less so with the two benzodiazepines. The process of learning is instead moderately accelerated in the case of a temporal discrimination and of a conditioned avoidance response CAR in the shuttle-box. The hypothesis is proposed that the phenomena described depend on the different pharmacokinetics of arginine pyroglutamate that ensures brain concentrations sufficient to block the activity of depressive compounds but is not capable of influencing in a significant way the spontaneous and specialized behaviour of normal animals. "


Nootropics Archive Home